Marjo Nylund

10PUBLICATIONS
30CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Sensory systemsNeurology and neuromuscular diseasesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2026
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis.

|Sep 15, 2025
Predictors of risk of secondary progression in multiple sclerosis.

Sini Laaksonen, Marcus Sucksdorff, Anna Vuorimaa

|Aug 04, 2025
Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain.

Tanja Sjöros, Maija Saraste, Markus Matilainen

|Jul 03, 2025
Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [11C]UCB-J-PET Imaging.

Amelie Luoma, Markus Matilainen, Jouni Mikael Tuisku

|May 16, 2025
Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis.

Venla Ahola, Maija Saraste, Marjo Nylund

|Apr 29, 2025
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis.

Luisa Klotz, Joost Smolders, Jussi Lehto

Pageof 2

Frequent Collaborators

8 joint publications

Laura M Airas

5 joint publications

Markus Matilainen

2 joint publications

Jouni Tuisku

2 joint publications

Anna Vuorimaa